Home - Products - GPCR/G Protein - Cannabinoid Receptor - Repertaxin

Repertaxin

CAS No. 266359-83-5

Repertaxin ( Repertaxin; DF 1681Y )

Catalog No. M17461 CAS No. 266359-83-5

Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).

Purity : 98%

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	65	In Stock
5MG	110	In Stock
10MG	177	In Stock
25MG	372	In Stock
50MG	556	In Stock
100MG	791	In Stock
500MG	1575	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Repertaxin
Note

Research use only, not for human use.
Brief Description

Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
Description

Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
Synonyms

Repertaxin; DF 1681Y
Pathway

GPCR/G Protein
Target

Cannabinoid Receptor
Recptor

CXCR1; CXCR2
Research Area

Inflammation/Immunology
Indication

——

Chemical Information

CAS Number

266359-83-5
Formula Weight

283.39
Molecular Formula

C14H21NO3S
Purity

98%
Solubility

DMSO : ≥ 500 mg/mL; 1764.35 mM
SMILES

CS(=O)(=O)NC(=O)[C@@H](c1ccc(CC(C)C)cc1)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Moriconi A, et al. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. J Med Chem. 2007 Aug 23;50(17):3984-4002.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Tetrahydromagnolol

Tetrahydromagnolol can activate cannabinoid (CB) receptors.
CB1 antagonist 2

CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
Pravadoline

Pravadoline is a cannabinoid receptor agonist. Pravadoline inhibited the PGs synthesis in mouse brain and displayed antinociceptive activity in rodents subjected to a variety of thermal, chemical, and mechanical nociceptive stimuli.

Sign In Join Free